Published in Eur J Haematol on May 01, 1993
Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor. J Immunother (2009) 2.35
Entering the era of targeted therapy for chronic lymphocytic leukemia: impact on the practicing clinician. J Clin Oncol (2014) 1.65
Pneumocystis carinii pneumonia as a complication of bendamustine monotherapy in a patient with advanced progressive breast cancer. J Cancer Res Clin Oncol (2003) 1.04
Cancer immunotherapy: the role regulatory T cells play and what can be done to overcome their inhibitory effects. Curr Mol Med (2009) 0.91
Fludarabine in the management of malignant lymphomas. Drugs (1994) 0.75
Immunological and genetic abnormalities in chronic lymphocytic leukaemia. Impact of the purine analogues. Drugs (1994) 0.75
Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. N Engl J Med (1995) 6.52
[The 'Anemia in the midwife practice' standard issued by the Royal Dutch Organisation of Midwives: a risk of not recognizing iron deficiency and hemoglobinopathy]. Ned Tijdschr Geneeskd (2002) 2.13
Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? Lancet (1995) 2.00
Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion (1999) 1.77
Primary extranodal and nodal non-Hodgkin's lymphoma. A survey of a population-based registry. Eur J Cancer Clin Oncol (1989) 1.51
A population-based registry on paraproteinaemia in The Netherlands. Comprehensive Cancer Centre West, Leiden, The Netherlands. Br J Haematol (1997) 1.43
[Radioactive phosphorus (32P); an old but not bad treatment for polycythemia vera]. Ned Tijdschr Geneeskd (1996) 1.40
Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions. Lancet (1977) 1.37
Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost (1998) 1.21
Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study. J Clin Oncol (1996) 1.21
Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers. Arterioscler Thromb Vasc Biol (1998) 1.09
The 5a-chromosome abnormality in haematological disorders: a collaborative study of 34 cases from the Netherlands. Br J Haematol (1982) 1.08
Clozapine-induced agranulocytosis: haematopoietic growth factors indicated? Neth J Med (1999) 1.06
RBC antibody persistence. Transfusion (2000) 1.04
Continuous infusion of low-dose 5-Aza-2'-deoxycytidine in elderly patients with high-risk myelodysplastic syndrome. Leukemia (1997) 1.01
Aplastic anaemia. Histological investigation of methacrylate embedded bone marrow biopsy specimens; correlation with survival after conventional treatment in 15 adult patients. Br J Haematol (1977) 0.91
Megakaryoblastic leukaemia (acute myelofibrosis): a report of three cases. Br J Haematol (1979) 0.89
Decreased coagulability has no clinically relevant effect on atherogenesis: observations in individuals with a hereditary bleeding tendency. Circulation (2001) 0.88
Fibrinopeptide A immunoreactivity in human plasma. Thromb Res (1974) 0.87
Further evidence for the lymphocytic nature of leukaemic reticuloendotheliosis (hairy-cell leukaemia). Br J Haematol (1974) 0.85
Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases. Br J Haematol (1987) 0.84
Causes of a negative ethanol gelation test in diffuse intravascular coagulation. Thromb Diath Haemorrh (1974) 0.83
Population-based registration of non-Hodgkin lymphoma in the region covered by the Comprehensive Cancer Centre West. The registry of diagnosis and therapy. Neth J Med (1986) 0.83
Experimental drug-induced aplastic anaemia. Clin Haematol (1980) 0.83
Continuous infusion of low-dose 5-Aza-2'-deoxycytidine in elderly patients with high-risk myelodysplastic syndrome. Leukemia (1997) 0.81
Splenomegaly associated with chronic consumption coagulopathy. Acta Med Scand (1974) 0.81
Significance of in vitro cultures in myelodysplastic syndromes. Scand J Haematol (1986) 0.81
Very mild pathology in a case of Hb S/beta0-thalassemia in combination with a homozygosity for the alpha-thalassemia 3.7 kb deletion. Hemoglobin (2000) 0.81
der(1)t(1;9): a specific chromosome abnormality in polycythemia vera? Cytogenetic and in situ hybridization studies. Cancer Genet Cytogenet (1989) 0.80
Trisomy 6 associated with aplastic anemia. Hum Genet (1976) 0.80
Mechanisms in aplastic anaemia. Lancet (1977) 0.79
Iliac bone marrow trephine biopsy: some remarks on the technique. Neth J Med (1978) 0.79
Busulphan aplasia in rabbits: a model for human aplastic anaemia. Br J Haematol (1982) 0.79
Acquired aplastic anemia in adults. IV. Histological and CFU studies in transplanted and non-transplanted patients. Scand J Haematol (1977) 0.78
Evidence of fibrinogen breakdown by leukocyte enzymes in a patient with acute promyelocytic leukemia. Haemostasis (1985) 0.78
The in vitro growth pattern of human bone marrow in methylcellulose stimulated by different concentrations of conditioned medium. Scand J Haematol (1984) 0.78
Acquired aplastic anaemia in adults. I. A retrospective analysis of 40 cases: single factors influencing the prognosis. Acta Haematol (1977) 0.78
Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma. J Clin Oncol (1997) 0.77
Use of antithrombin concentrate in stable diffuse intravascular coagulation. A case report. Acta Haematol (1982) 0.76
Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group. J Clin Oncol (1997) 0.76
Acidic citrate stabilizes blood samples for assay of total homocysteine. Clin Chem (1998) 0.76
Detection of monosomy 7 and trisomy 8 in myeloid neoplasia: a comparison of banding and fluorescence in situ hybridization. Blood (1993) 0.75
Neutrophil increment after single injection of CSF. Br J Haematol (1994) 0.75
Anti-thymocyte globulin (ATG) can eliminate platelet refractoriness. Blut (1981) 0.75
The factor VIII ratio in normal and pathological pregnancies. Eur J Obstet Gynecol Reprod Biol (1983) 0.75
[The recommended daily intake of folic acid is insufficient for optimum homocysteine level]. Ned Tijdschr Geneeskd (1998) 0.75
Anti-thymocyte globulin treatment for aplastic anemia. Scand J Haematol (1982) 0.75
111Indium-chloride bone marrow scintigraphy in aplastic anaemia. Scand J Haematol (1981) 0.75
[Treatment of acute myelogenous leukemia in adults; an account of the years 1968 to 1975]. Ned Tijdschr Geneeskd (1977) 0.75
Histology of bone marrow failure, a follow-up study in aplastic anaemia. Haematol Blood Transfus (1979) 0.75
Acute myelomonocytic leukaemia and acquired haemophilia A with severe cutaneous haemorrhage. Scand J Haematol (1986) 0.75
[Are hematologic reference values applicable to the healthy elderly?]. Ned Tijdschr Geneeskd (1989) 0.75
Unrelated bone marrow transplantation as a rescue procedure following inadvertent loss of an autologous bone marrow graft. Bone Marrow Transplant (1996) 0.75
[A new form of nursing]. Tijdschr Ziekenverpl (1974) 0.75
An IVS1-116 (A-->G) acceptor splice site mutation in the alpha 2 globin gene causing alpha + thalassaemia in two Dutch families. Br J Haematol (1996) 0.75
The contribution of in vitro cultures to the elucidation of the pathogenesis of aplastic anaemia. Haematol Blood Transfus (1979) 0.75
Extreme potassium loss in a patient with severe graft versus host disease. Scand J Haematol (1980) 0.75
[Clinical thinking and decision making in practice. The internist as consultant for a patient with unexplained anemia in cardiology department]. Ned Tijdschr Geneeskd (2001) 0.75
A case of non-beta-globin gene linked beta thalassaemia in a Dutch family with two additional alpha-gene defects: the common -alpha3.7 deletion and the rare IVS1-116 (A-->G) acceptor splice site mutation. Br J Haematol (1998) 0.75
Glycoprotein Ib polymorphism in a patient with Glanzmann's thrombasthenia type I (case report) Thromb Haemost (1990) 0.75
The elevated risk for venous thrombosis in persons with hyperhomocysteinemia is not reflected by the endogenous thrombin potential. Thromb Haemost (1999) 0.75
[Von Willebrand's disease]. Ned Tijdschr Geneeskd (1982) 0.75
Corticosteroids and experimental intravascular coagulation. Scand J Haematol (1974) 0.75
Inhibition of CFUE and BFUE by mononuclear peripheral blood cells during chronic benzene treatment in rabbits. Acta Haematol (1982) 0.75
The effect of anticoagulants on the size of platelets in blood smears in the course of time. Clin Lab Haematol (1991) 0.75
Trisomy of chromosome 22 in acute myelomonocytic leukemia. Cancer Genet Cytogenet (1986) 0.75
[Glaphenine-induced intravascular hemolysis with acute kidney insufficiency as a consequence of IgG anti-glaphenine antibodies]. Ned Tijdschr Geneeskd (1987) 0.75
[Bone marrow transplantation and (or) immunosuppression with antithymocyte globulin in the treatment of aplastic anemia]. Ned Tijdschr Geneeskd (1978) 0.75
Variability of the methionine loading test: no effect of a low protein diet. Ann Clin Biochem (1996) 0.75
[A patient with behavior disorders]. Ned Tijdschr Geneeskd (1972) 0.75
Bone-marrow aspiration. Br Med J (Clin Res Ed) (1981) 0.75
Chronic lymphocytic leukaemia and associated second malignancy. Neth J Med (1986) 0.75
Nonradioactive in situ hybridisation of the translocation t(1;7) in myeloid malignancies. Genes Chromosomes Cancer (1992) 0.75
[Anemia in women]. Tijdschr Ziekenverpl (1975) 0.75
Treatment of aplastic anaemia by antilymphocyte globulin with or without marrow infusion. Clin Haematol (1978) 0.75
Fibrinogen and its derivatives in intravascular coagulation. A review. Neth J Med (1975) 0.75
Scintigraphic aspects of 111In-chloride bone marrow scintigraphy in aplastic anaemia. Diagn Imaging (1981) 0.75
The prognosis of aplastic anaemia (AA) and the indication for bone marrow transplantation [proceedings]. Pathol Biol (Paris) (1978) 0.75
[Hyperhomocysteinemia as a risk factor for venous thrombosis]. Ned Tijdschr Geneeskd (1999) 0.75
[Agranulocytosis caused by clozapine: the importance of leukocyte monitoring and efficacy of hematopoietic growth factors]. Ned Tijdschr Geneeskd (1995) 0.75
The effect of antithymocyte globulin on abnormal lymphocyte transformation in patients with aplastic anemia. Haematol Blood Transfus (1979) 0.75
Immunological investigations in aplastic anemia patients. Acta Haematol (1984) 0.75
Teratoma of the lung in a hemophilic patient. Acta Haematol (1983) 0.75
[Splenectomy as therapy for esophageal varices in a myeloproliferative syndrome]. Ned Tijdschr Geneeskd (1990) 0.75
Adult T-cell leukaemia lymphoma (ATLL) associated with human T-cell leukaemia virus (HTLV). Case report and immunological studies with the neoplastic T-cells of a Caribbean patient. Neth J Med (1985) 0.75
[A patient with acute non-lymphatic leukemia 2 years after non-Hodgkin lymphoma]. Ned Tijdschr Geneeskd (1988) 0.75
Acquired aplastic anaemia in adults. II. Conventional treatment: retrospective study in 40 patients. Acta Haematol (1977) 0.75
Mitoxantrone, teniposide, chlorambucil and prednisone (MVLP) for relapsed non-Hodgkin's lymphoma. The impact of advanced age and performance status. Neth J Med (1993) 0.75
In vitro tests for distinguishing possible immune-mediated aplastic anemia from transfusion-induced sensitization. Blood (1980) 0.75
Hyaline-vascular type Castleman's disease with concomitant malignant B-cell lymphoma. Acta Haematol (1992) 0.75
Retrospective study and perspectives in the treatment of meningeal leukaemia. Folia Med Neerl (1972) 0.75
Aplastic anaemia in adults. Further evidence concerning the significance of the inflammatory infiltrate in methacrylate-embedded bone marrow biopsy specimens. Bibl Haematol (1978) 0.75